KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Working Capital Changes (2016 - 2026)

Pacira BioSciences has reported Other Working Capital Changes over the past 17 years, most recently at $4.5 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 12.77% year-over-year to $4.5 million; the TTM value through Mar 2026 reached $548000.0, down 90.92%, while the annual FY2025 figure was $1.2 million, 2086.89% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was $4.5 million at Pacira BioSciences, up from -$12.7 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $13.4 million in Q2 2025 and troughed at -$12.7 million in Q4 2025.
  • A 5-year average of $791176.5 and a median of $2.1 million in 2022 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: surged 1777.17% in 2022 and later tumbled 232.76% in 2024.
  • Year by year, Other Working Capital Changes stood at $2.1 million in 2022, then plummeted by 190.24% to -$1.9 million in 2023, then tumbled by 232.76% to -$6.4 million in 2024, then tumbled by 98.45% to -$12.7 million in 2025, then skyrocketed by 135.73% to $4.5 million in 2026.
  • Business Quant data shows Other Working Capital Changes for PCRX at $4.5 million in Q1 2026, -$12.7 million in Q4 2025, and -$4.7 million in Q3 2025.